A controversial company that claimed to develop hypoallergenic cats and dogs will bow out of the companion animal business and launch a new venture focused on veterinary diagnostic services starting next year, according to a statement sent out in their corporate newsletter this Sunday (29th November).
"Following our recent acquisition, the business will be taking a new direction from 2010, specifically, fine-tuning and launching our proprietary veterinary genetic molecular diagnostic products," reads a statement from the company, called Allerca Lifestyle Pets. The statement did not indicate which company had acquired it, but noted that this information, as well as details on its new business model, will be announced publicly early next year. Allerca said that it will stop taking new orders for its two breeds of hypoallergenic cats and one dog breed as of December 31, 2010, but will continue filling already-placed orders through 2010 and early...
Interested in reading more?
The Scientist ARCHIVED CONTENT
ACCESS MORE THAN 30,000 ARTICLES ACROSS MANY TOPICS AND DISCIPLINES
Become a Member of
Receive full access to more than 35 years of archived stories, digital editions of The Scientist Magazine, and much more!